{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:34:21Z","timestamp":1792427661480,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T00:00:00Z","timestamp":1633219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T00:00:00Z","timestamp":1633219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00198-021-06101-3","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T21:05:21Z","timestamp":1633381521000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The use of oral glucocorticoids and the risk of major osteoporotic fracture in patients with myasthenia gravis"],"prefix":"10.1007","volume":"33","author":[{"given":"Zohreh","family":"Safipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0222-2865","authenticated-orcid":false,"given":"Rogier","family":"van der Zanden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3984-2232","authenticated-orcid":false,"given":"Joop","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3050-2728","authenticated-orcid":false,"given":"Paddy","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3837-8319","authenticated-orcid":false,"given":"Frank","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4503-6408","authenticated-orcid":false,"given":"Johanna H. M.","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,3]]},"reference":[{"issue":"12","key":"6101_CR1","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1212\/WNL.0000000000000804","volume":"83","author":"J-H Yeh","year":"2014","unstructured":"Yeh J-H, Chen H-J, Chen Y-K, Chiu H-C, Kao C-H (2014) Increased risk of osteoporosis in patients with myasthenia gravis: a population-based cohort study. Neurology 83(12):1075\u20131079. https:\/\/doi.org\/10.1212\/WNL.0000000000000804","journal-title":"Neurology"},{"issue":"2","key":"6101_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","volume":"36","author":"C Farmakidis","year":"2018","unstructured":"Farmakidis C, Pasnoor M, Dimachkie MM, Barohn RJ (2018) Treatment of myasthenia gravis. Neurol Clin 36(2):311\u2013337. https:\/\/doi.org\/10.1016\/j.ncl.2018.01.011","journal-title":"Neurol Clin"},{"issue":"5","key":"6101_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1046\/j.1365-2796.2003.01219.x","volume":"254","author":"P Vestergaard","year":"2003","unstructured":"Vestergaard P, Olsen ML, Paaske Johnsen S, Rejnmark L, S\u00f8rensen HT, Mosekilde L (2003) Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark. J Intern Med 254(5):486\u2013493. https:\/\/doi.org\/10.1046\/j.1365-2796.2003.01219.x","journal-title":"J Intern Med"},{"issue":"6","key":"6101_CR4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Van Staa","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15(6):993\u20131000. https:\/\/doi.org\/10.1359\/jbmr.2000.15.6.993","journal-title":"J Bone Miner Res"},{"issue":"4","key":"6101_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2796.2005.01467.x","volume":"257","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Fracture risk associated with systemic and topical corticosteroids. J Intern Med 257(4):374\u2013384. https:\/\/doi.org\/10.1111\/j.1365-2796.2005.01467.x","journal-title":"J Intern Med"},{"issue":"1","key":"6101_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/art.22294","volume":"56","author":"F De Vries","year":"2007","unstructured":"De Vries F, Bracke M, Leufkens HGM, Lammers J-WJ, Cooper C, Van Staa TP (2007) Fracture risk with intermittent high-dose oral glucocorticoid therapy. Arthritis Rheum 56(1):208\u2013214. https:\/\/doi.org\/10.1002\/art.22294","journal-title":"Arthritis Rheum"},{"issue":"12","key":"6101_CR7","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP van Staa","year":"2000","unstructured":"van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology 39(12):1383\u20131389. https:\/\/doi.org\/10.1093\/rheumatology\/39.12.1383","journal-title":"Rheumatology"},{"issue":"7\u20138","key":"6101_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.micron.2005.07.009","volume":"36","author":"L Dalle Carbonare","year":"2005","unstructured":"Dalle Carbonare L, Bertoldo F, Valenti MT et al (2005) Histomorphometric analysis of glucocorticoid-induced osteoporosis. Micron 36(7\u20138):645\u2013652. https:\/\/doi.org\/10.1016\/j.micron.2005.07.009","journal-title":"Micron"},{"issue":"8","key":"6101_CR9","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/art.40137","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA et al (2017) American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumato 69(8):1521\u20131537. https:\/\/doi.org\/10.1002\/art.40137","journal-title":"Arthritis Rheumato"},{"issue":"1","key":"6101_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","volume":"12","author":"J Compston","year":"2017","unstructured":"The National Osteoporosis Guideline Group (NOGG), Compston J, Cooper A (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos 12(1):43. https:\/\/doi.org\/10.1007\/s11657-017-0324-5","journal-title":"Arch Osteoporos"},{"key":"6101_CR11","unstructured":"Lems WF, Appelman CLM (2011) Derde herziene richtlijn osteoporose en fractuurpreventie. Nederlandse Vereniging voor Reumatologie. https:\/\/www.volksgezondheidenzorg.info\/bestanden\/documenten\/cbo-richtlijn-osteoporose-en-fractuurpreventie-2011 Accessed February 4, 2021"},{"issue":"2","key":"6101_CR12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00198-012-1970-5","volume":"24","author":"S Pouwels","year":"2013","unstructured":"Pouwels S, de Boer A, Javaid MK et al (2013) Fracture rate in patients with myasthenia gravis: the general practice research database. Osteoporos Int 24(2):467\u2013476. https:\/\/doi.org\/10.1007\/s00198-012-1970-5","journal-title":"Osteoporos Int"},{"issue":"5","key":"6101_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126579","volume":"10","author":"S Konno","year":"2015","unstructured":"Konno S, Suzuki S, Masuda M et al (2015) Association between glucocorticoid-induced osteoporosis and myasthenia gravis: a cross-sectional study. PLoS ONE 10(5):e0126579. https:\/\/doi.org\/10.1371\/journal.pone.0126579","journal-title":"PLoS ONE"},{"issue":"3","key":"6101_CR14","first-page":"263","volume":"46","author":"TF Andersen","year":"1999","unstructured":"Andersen TF, Madsen M, J\u00f8rgensen J, Mellemkjoer L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46(3):263\u2013268","journal-title":"Dan Med Bull"},{"issue":"26","key":"6101_CR15","first-page":"3741","volume":"157","author":"J Mosbech","year":"1995","unstructured":"Mosbech J, J\u00f8rgensen J, Madsen M, Rostgaard K, Thornberg K, Poulsen TD (1995) The national patient registry. Evaluation of data quality Ugeskr Laeger 157(26):3741\u20133745","journal-title":"Evaluation of data quality Ugeskr Laeger"},{"issue":"1","key":"6101_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/aje\/kwf007","volume":"156","author":"P Vestergaard","year":"2002","unstructured":"Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn\u2019s disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 156(1):1\u201310. https:\/\/doi.org\/10.1093\/aje\/kwf007","journal-title":"Am J Epidemiol"},{"issue":"3","key":"6101_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JRS-1997-10309","volume":"10","author":"GL Nielsen","year":"1997","unstructured":"Nielsen GL, S\u00f8rensen HT, Zhou W, Steffensen FH, Olsen J (1997) The Pharmacoepidemiologic Prescription Database of North Jutland - a valid tool in pharmacoepidemiological research. Int J Risk Saf Med 10(3):203\u2013205. https:\/\/doi.org\/10.3233\/JRS-1997-10309","journal-title":"Int J Risk Saf Med"},{"issue":"2","key":"6101_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00198-012-2043-5","volume":"24","author":"P Vestergaard","year":"2013","unstructured":"Vestergaard P, Prieto-Alhambra D, Javaid MK, Cooper C (2013) Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose. Osteoporos Int 24(2):671\u2013680. https:\/\/doi.org\/10.1007\/s00198-012-2043-5","journal-title":"Osteoporos Int"},{"key":"6101_CR19","unstructured":"Kanis J. Assessment of osteoporosis at the primary health-care level (2007) https:\/\/www.sheffield.ac.uk\/FRAX\/pdfs\/WHO_Technical_Report.pdf"},{"issue":"9","key":"6101_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1093\/oxfordjournals.aje.a116396","volume":"135","author":"S Wacholder","year":"1992","unstructured":"Wacholder S, McLaughlin JK, Silverman DT, Mandel JS (1992) Selection of controls in case-control studies. I Principles Am J Epidemiol 135(9):1019\u20131028. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a116396","journal-title":"I Principles Am J Epidemiol"},{"key":"6101_CR21","unstructured":"WHO. ATC classification index with DDDs. https:\/\/www.whocc.no\/atc_ddd_index\/"},{"issue":"1","key":"6101_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/aje\/kwv311","volume":"184","author":"A Lalmohamed","year":"2016","unstructured":"Lalmohamed A, van Staa TP, Vestergaard P et al (2016) Statins and risk of lower limb revision surgery: the influence of differences in study design using electronic health records from the United Kingdom and Denmark. Am J Epidemiol 184(1):58\u201366. https:\/\/doi.org\/10.1093\/aje\/kwv311","journal-title":"Am J Epidemiol"},{"key":"6101_CR23","unstructured":"Stuart-Buttle CD, Read JD, Sanderson HF, Sutton YM (1996) A language of health in action: read codes, classifications and groupings. Proc Conf Am Med Inform Assoc AMIA Fall Symp\u00a075\u20139.\u00a0 https:\/\/pubmed.ncbi.nlm.nih.gov\/8947631\/"},{"key":"6101_CR24","doi-asserted-by":"publisher","unstructured":"Kassardjian C, Widdifield J, Paterson JM, et al. Fracture risk in patients with myasthenia gravis: a population-based cohort study. JND. Published online February 4, 2021:1\u20138. https:\/\/doi.org\/10.3233\/JND-200612","DOI":"10.3233\/JND-200612"},{"issue":"4","key":"6101_CR25","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.febslet.2010.01.001","volume":"584","author":"T Sato","year":"2010","unstructured":"Sato T, Abe T, Chida D et al (2010) Functional role of acetylcholine and the expression of cholinergic receptors and components in osteoblasts. FEBS Lett 584(4):817\u2013824. https:\/\/doi.org\/10.1016\/j.febslet.2010.01.001","journal-title":"FEBS Lett"},{"issue":"2","key":"6101_CR26","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00441-009-0871-1","volume":"338","author":"M En-Nosse","year":"2009","unstructured":"En-Nosse M, Hartmann S, Trinkaus K et al (2009) Expression of non-neuronal cholinergic system in osteoblast-like cells and its involvement in osteogenesis. Cell Tissue Res 338(2):203\u2013215. https:\/\/doi.org\/10.1007\/s00441-009-0871-1","journal-title":"Cell Tissue Res"},{"issue":"8","key":"6101_CR27","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1002\/jbmr.4024","volume":"35","author":"Y Ma","year":"2020","unstructured":"Ma Y, Elefteriou F (2020) Brain-derived acetylcholine maintains peak bone mass in adult female mice. J Bone Miner Res 35(8):1562\u20131571. https:\/\/doi.org\/10.1002\/jbmr.4024","journal-title":"J Bone Miner Res"},{"key":"6101_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/9781118344828","volume-title":"Textbook of pharmacoepidemiology","author":"B Strom","year":"2013","unstructured":"Strom B, Kimmel S, Hennessy S (2013) Textbook of pharmacoepidemiology. Wiley-Blackwell, Hoboken"},{"key":"6101_CR29","volume-title":"Modern epidemiology","author":"K Rothman","year":"2008","unstructured":"Rothman K, Greenland S, Lash T (2008) Modern epidemiology. Lippincott Williams & Wilkins, Philadelphia"},{"issue":"2","key":"6101_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.clineuro.2003.12.001","volume":"106","author":"N Wakata","year":"2004","unstructured":"Wakata N, Nemoto H, Sugimoto H et al (2004) Bone density in myasthenia gravis patients receiving long-term prednisolone therapy. Clin Neurol Neurosurg 106(2):139\u2013141. https:\/\/doi.org\/10.1016\/j.clineuro.2003.12.001","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06101-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-06101-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06101-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T07:06:08Z","timestamp":1644822368000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-06101-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["6101"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-06101-3","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,3]]},"assertion":[{"value":"4 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ZS: No conflict of interest.JD: No conflict of interest.JB: No conflict of interest.PJ: No conflict of interest.PV is the head of research at Steno Diabetes Center North Jutland, funded by the Novo Nordisk Foundation.FV currently supervises three PhD students who are employed with F. Hoffmann La Roche Ltd. (Basel, Switzerland, and Welwyn Garden City, UK). He has not received any feeds or reimbursements for this. The topics of their PhD theses do not relate to the current manuscript.RZ: No conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}